Hyperfine, Inc. (HYPR): Total Assets
$55.26M
As of 2025-12-31
$63.00M
As of 2026-06-30
-25.6%
3-year compound annual growth
-5.0%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $55.26M | -6.2% | 2026-03-18, Balance as of period end |
| 2024-12-31 | $58.90M | -37.5% | 2026-03-18, Balance as of period end |
| 2023-12-31 | $94.20M | -29.7% | 2025-03-17, Balance as of period end |
| 2022-12-31 | $134.05M | -33.8% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $202.47M | +183.1% | 2023-03-22, Balance as of period end |
| 2020-12-31 | $71.53M | n/a | 2022-03-25, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $55.26M | -6.2% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.16M | +8.1% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $4.99M | +4.9% |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $23.02M | +278.2% |
| Precision Optics Corporation, Inc. (POCI) | 2025-06-30 | $19.79M | +17.0% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $6.12M | -38.0% |
| electroCore, Inc. (ECOR) | 2025-12-31 | $18.67M | -8.8% |
| Stereotaxis, Inc. (STXS) | 2025-12-31 | $52.25M | +11.8% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $6.40M | +34.6% |
Compare HYPR, CV, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗